|
RECQL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62614366416847E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33146835171283E-15 |
| Normal-vs-Stage2 |
7.52740000000696E-05 |
| Normal-vs-Stage3 |
2.47300000000283E-06 |
| Normal-vs-Stage4 |
3.65170000005133E-06 |
| Stage1-vs-Stage2 |
9.406800E-01 |
| Stage1-vs-Stage3 |
4.177600E-01 |
| Stage1-vs-Stage4 |
4.547800E-01 |
| Stage2-vs-Stage3 |
6.538600E-01 |
| Stage2-vs-Stage4 |
5.304200E-01 |
| Stage3-vs-Stage4 |
2.537600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.66133814775094E-16 |
| Normal-vs-AfricanAmerican |
1.024390E-03 |
| Normal-vs-Asian |
9.680200E-03 |
| Caucasian-vs-AfricanAmerican |
1.038450E-02 |
| Caucasian-vs-Asian |
2.148600E-01 |
| AfricanAmerican-vs-Asian |
1.129740E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67499347725197E-12 |
| Normal-vs-Female |
3.56137341839258E-12 |
| Male-vs-Female |
4.498000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.501200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.66577862614758E-12 |
| Normal-vs-Age(61-80Yrs) |
1.0350054147068E-11 |
| Normal-vs-Age(81-100Yrs) |
3.496400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.533000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.643400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.768600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.345600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.258600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.505000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.87750000178045E-08 |
| Normal-vs-Grade 2 |
4.31876756579186E-14 |
| Normal-vs-Grade 3 |
9.99730298545387E-11 |
| Normal-vs-Grade 4 |
5.83079999999514E-05 |
| Grade 1-vs-Grade 2 |
5.387600E-01 |
| Grade 1-vs-Grade 3 |
9.459600E-02 |
| Grade 1-vs-Grade 4 |
6.024200E-01 |
| Grade 2-vs-Grade 3 |
3.885800E-02 |
| Grade 2-vs-Grade 4 |
8.134200E-01 |
| Grade 3-vs-Grade 4 |
2.185200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62458935193399E-12 |
| Normal-vs-ccB subtype |
2.70750000197495E-09 |
| ccA subtype-vs-ccB subtype |
3.584000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.85780296596749E-12 |
| Normal-vs-N1 |
1.063760E-02 |
| N0-vs-N1 |
4.530400E-01 |
|
|
